Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.26USD
4:00pm EDT
Change (% chg)

$-0.05 (-3.45%)
Prev Close
$1.30
Open
$1.31
Day's High
$1.31
Day's Low
$1.25
Volume
214
Avg. Vol
29,251
52-wk High
$3.09
52-wk Low
$1.11

Latest Key Developments (Source: Significant Developments)

Acasti Pharma announces pricing for its public offering of units
Friday, 10 Feb 2017 04:26pm EST 

Acasti Pharma Inc : Acasti Pharma announces pricing for its public offering of units .Acasti Pharma- entered agency agreement with Echelon Wealth Partners as sole bookrunner, lead agent; agent to offer units for proceeds of C$4.5 million-C$8 million.  Full Article

Acasti Pharma Q3 loss C$0.22/shr
Thursday, 12 Jan 2017 05:15pm EST 

Acasti Pharma Inc : Acasti Pharma reports third quarter 2017 financial results . Q3 loss per share C$0.22 . Acasti pharma - Had cash,short-term investments of $5.8 million as of Nov 30, 2016 .Acasti Pharma - if co doesn't raise additional funds, there exists material uncertainty casting substantial doubt about ability to continue as going concern.  Full Article

Acasti Pharma announces proposed offering of units
Monday, 5 Dec 2016 05:38pm EST 

Acasti Pharma Inc : Acasti Pharma announces proposed offering of units .Acasti Pharma-Received receipt for a preliminary short form prospectus for minimum gross proceeds of CAD$6.5 million, maximum gross proceeds of CAD$10 million.  Full Article

Acasti Pharma Q2 loss per share $0.22
Tuesday, 11 Oct 2016 05:00pm EDT 

Acasti Pharma Inc : reports second quarter 2017 financial results . Qtrly loss per share $0.22 . if co does not raise additional funds, there exists uncertainty that casts substantial doubt about ability to continue as going concern .Management has reasonable expectation that corporation will be able to raise additional funds.  Full Article

Acasti posts qtrly loss per share of $0.29
Monday, 11 Jul 2016 05:30pm EDT 

Acasti Pharma Inc: Acasti announces first quarter results .Qtrly loss per share $0.29.  Full Article

Acasti Pharma says Jan D'Alvise named as CEO
Thursday, 12 May 2016 08:08am EDT 

Acasti Pharma Inc : Says Jan D'Alvise appointed as president and chief executive officer effective June 1, 2016 .Jan D'Alvise appointed president & CEO of Acasti Pharma.  Full Article

Acasti Pharma Inc says appointment of Roderick Carter, as Executive Chairman of the Board
Tuesday, 1 Mar 2016 08:00am EST 

Acasti Pharma Inc:Says appointment of Roderick Carter, as Executive Chairman of the Board.  Full Article

Acasti Pharma Inc announces departure of chief financial officer
Wednesday, 29 Apr 2015 06:35pm EDT 

Acasti Pharma Inc:Says departure of andré godin as chief financial officer effective immediately.  Full Article

More From Around the Web